EXPION360 INC (XPON)

US30218B1008 - Common Stock

2.5  -0.05 (-1.96%)

Fundamental Rating

2

Taking everything into account, XPON scores 2 out of 10 in our fundamental rating. XPON was compared to 91 industry peers in the Electrical Equipment industry. XPON may be in some trouble as it scores bad on both profitability and health. XPON is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year XPON has reported negative net income.
XPON had a negative operating cash flow in the past year.

1.2 Ratios

With a Return On Assets value of -96.02%, XPON is not doing good in the industry: 85.56% of the companies in the same industry are doing better.
XPON has a Return On Equity of -333.07%. This is in the lower half of the industry: XPON underperforms 76.67% of its industry peers.
Industry RankSector Rank
ROA -96.02%
ROE -333.07%
ROIC N/A
ROA(3y)-60.02%
ROA(5y)N/A
ROE(3y)-137.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of XPON (24.47%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of XPON has grown nicely.
XPON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.29%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

XPON does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XPON has been reduced compared to 1 year ago.
XPON has a worse debt/assets ratio than last year.

2.2 Solvency

XPON has an Altman-Z score of -6.04. This is a bad value and indicates that XPON is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -6.04, XPON is not doing good in the industry: 81.11% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.90 indicates that XPON is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.90, XPON is doing worse than 68.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z -6.04
ROIC/WACCN/A
WACC8.6%

2.3 Liquidity

XPON has a Current Ratio of 1.37. This is a normal value and indicates that XPON is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.37, XPON is not doing good in the industry: 72.22% of the companies in the same industry are doing better.
A Quick Ratio of 0.54 indicates that XPON may have some problems paying its short term obligations.
XPON's Quick ratio of 0.54 is on the low side compared to the rest of the industry. XPON is outperformed by 84.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.54

5

3. Growth

3.1 Past

XPON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.01%.
The Revenue for XPON has decreased by -17.24% in the past year. This is quite bad
The Revenue has been growing by 56.18% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-81.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.86%
Revenue 1Y (TTM)-17.24%
Revenue growth 3Y56.18%
Revenue growth 5YN/A
Sales Q2Q%-25.91%

3.2 Future

XPON is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.11% yearly.
Based on estimates for the next years, XPON will show a quite strong growth in Revenue. The Revenue will grow by 11.72% on average per year.
EPS Next Y66%
EPS Next 2Y37.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.28%
Revenue Next 2Y11.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

XPON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year XPON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

XPON's earnings are expected to grow with 37.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.11%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for XPON!.
Industry RankSector Rank
Dividend Yield N/A

EXPION360 INC

NASDAQ:XPON (11/21/2024, 2:30:16 PM)

2.5

-0.05 (-1.96%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.40M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -96.02%
ROE -333.07%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 24.47%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.37
Quick Ratio 0.54
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-81.01%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-17.24%
Revenue growth 3Y56.18%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y